Prof. Dr. Murat Kürtüncü Uluslararası Yayınları

Köseoğlu M, Gözübatık Çelik RG, Kürtüncü M. A case report with tuberculous
meningitis during fingolimod treatment. Mult Scler Relat Disord. 2020 Aug
15;46:102450. doi: 10.1016/j.msard.2020.102450. Epub ahead of print. PMID:
32862038.

Yilmaz V, Ulusoy C, Hajtovic S, Turkoglu R, Kurtuncu M, Tzartos J, Lazaridis
K, Tuzun E. Effects of Teriflunomide on B Cell Subsets in MuSK-Induced
Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis. Immunol
Invest. 2020 Jun 29:1-14. doi: 10.1080/08820139.2020.1785491. Epub ahead of
print. PMID: 32597289.

Polat Dunya C, Tulek Z, Kürtüncü M, Panicker JN, Eraksoy M. Effectiveness of
the transcutaneous tibial nerve stimulation and pelvic floor muscle training
with biofeedback in women with multiple sclerosis for the management of
overactive bladder. Mult Scler. 2020 Jun 9:1352458520926666. doi:
10.1177/1352458520926666. Epub ahead of print. Erratum in: Mult Scler. 2020 Jul
24;:1352458520945512. PMID: 32513049.

Sevim S, Demirkıran M, Terzi M, Yüceyar N, Taşdelen B, İdiman E, Kürtüncü M,
Boz C, Tuncel D, Karabudak R, Siva A, Özcan A, Neyal M, Göksel BK, Balal M, Şen
S, Ekmekçi Ö, Öksüz N, Kaya D. ‘Is RLS a harbinger and consequence of MS?:
Striking results of the ‘RELOMS-T’ study’. Mult Scler Relat Disord. 2020
Jul;42:102055. doi: 10.1016/j.msard.2020.102055. Epub 2020 Mar 16. PMID:
32473575.

Gündüz T, Kürtüncü M, Matur Z, Tüzün E, Limon U, Tanyıldız B, İzgi B, Erdoğan
N, Öge AE, Gürvit H, Bilgiç B, Akman-Demir G. Laboratory and clinical correlates
of brain atrophy in Neuro-Behçet’s disease. J Neurol Sci. 2020 Jul
15;414:116831. doi: 10.1016/j.jns.2020.116831. Epub 2020 Apr 19. PMID: 32380297.

AlSharoqi IA, Aljumah M, Bohlega S, Boz C, Daif A, El-Koussa S, Inshasi J,
Kurtuncu M, Müller T, Retief C, Sahraian MA, Shaygannejad V, Slassi I, Taha K,
Zakaria M, Sørensen PS. Immune Reconstitution Therapy or Continuous
Immunosuppression for the Management of Active Relapsing-Remitting Multiple
Sclerosis Patients? A Narrative Review. Neurol Ther. 2020 Jun;9(1):55-66. doi:
10.1007/s40120-020-00187-3. Epub 2020 Apr 15. PMID: 32297127; PMCID: PMC7229056.

Uygun Ö, Gündüz T, Eraksoy M, Kürtüncü M. Adult-onset 4H leukodystrophy: a
case presentation and review of the literature. Acta Neurol Belg. 2020 Feb 12.
doi: 10.1007/s13760-020-01297-3. Epub ahead of print. PMID: 32052360.

Yazgan YZ, Tarakci E, Tarakci D, Ozdincler AR, Kurtuncu M. Comparison of the
effects of two different exergaming systems on balance, functionality, fatigue,
and quality of life in people with multiple sclerosis: A randomized controlled
trial. Mult Scler Relat Disord. 2019 Dec 21;39:101902. doi:
10.1016/j.msard.2019.101902. Epub ahead of print. PMID: 31924591.

Polat Dunya C, Tulek Z, Vızvız GY, Gündüz T, Panicker JN, Kürtüncü M, Eraksoy
M. Validation of the Turkish version of the eight-item actionable bladder
symptom screening tool in multiple sclerosis. Neurourol Urodyn. 2020
Jan;39(1):243-252. doi: 10.1002/nau.24177. Epub 2019 Oct 6. PMID: 31588627.

Kürtüncü M, Yılmaz V, Akçay Hİ, Türkoğlu R, Altunrende B, Çınar SA, Ulusoy
C, Gündüz T, İçöz S, Kasap M, Çalışkan Z, Ötünç G, Eraksoy M, Tüzün E. Impact of
fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting
multiple sclerosis patients. J Neuroimmunol. 2019 Dec 15;337:577065. doi:
10.1016/j.jneuroim.2019.577065. Epub 2019 Sep 11. PMID: 31526917.

Ugurel E, Erdag E, Kucukali CI, Olcay A, Sanli E, Akbayir E, Kurtuncu M,
Gunduz T, Yilmaz V, Tuzun E, Vural B. Enhanced NLRP3 and DEFA1B Expression
During the Active Stage of Parenchymal Neuro-Behçet’s Disease. In Vivo. 2019
Sep-Oct;33(5):1493-1497. doi: 10.21873/invivo.11629. PMID: 31471397; PMCID:
PMC6755001.

Oezguen N, Yalcinkaya N, Kücükali CI, Dahdouli M, Hollister EB, Luna RA,
Türkoglu R, Kürtüncü M, Eraksoy M, Savidge TC, Tüzün E. Microbiota
stratification identifies disease-specific alterations in neuro-Behçet’s disease
and multiple sclerosis. Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):58-66.
Epub 2019 May 30. PMID: 31172918.

Agirgol S, Kurtuncu M, Gurbuzel M, Tasyurek I, Gunduz T. Psoriasiform
eruption caused by teriflunomide in a patient with multiple sclerosis. Clin
Toxicol (Phila). 2019 Nov;57(11):1125-1127. doi: 10.1080/15563650.2019.1581940.
Epub 2019 Feb 26. PMID: 30806096.

Aydin Ç, Çelik ŞY, İçöz S, Ulusoy C, Gündüz T, Demir GA, Kürtüncü M, Tüzün
E. Prognostic Factors in Anti-Neuronal Antibody Positive Patients. Noro
Psikiyatr Ars. 2018 May 4;55(2):189-194. doi: 10.29399/npa.23033. PMID:
30057463; PMCID: PMC6060648.

Timirci-Kahraman O, Karaaslan Z, Tuzun E, Kurtuncu M, Baykal AT, Gunduz T,
Tuzuner MB, Akgun E, Gurel B, Eraksoy M, Kucukali CI. Identification of
candidate biomarkers in converting and non-converting clinically isolated
syndrome by proteomics analysis of cerebrospinal fluid. Acta Neurol Belg. 2019
Mar;119(1):101-111. doi: 10.1007/s13760-018-0954-4. Epub 2018 Jun 5. PMID:
29873030.

Çakar A, Akçay Hİ, Gündüz T, Kürtüncü M. Paraplegia following lumbar
puncture: a rare complication in spinal dural arteriovenous fistula. Acta Neurol
Belg. 2018 Dec;118(4):543-545. doi: 10.1007/s13760-018-0951-7. Epub 2018 May 28.
PMID: 29808310.

Kurtuncu M, Arslan N. The influence on group games on the relationship
between children with disabilities and their healthy siblings: An experimental
study. J Pak Med Assoc. 2018 Mar;68(3):400-409. PMID: 29540875.

Samanci B, Ulukan Ç, Gündüz T, Kürtüncü M, Eraksoy M. Nasu-Hakola Disease.
Neurol India. 2018 Jan-Feb;66(1):263. doi: 10.4103/0028-3886.222875. PMID:
29323005.

Tülek Z, Polat C, Kürtüncü M, Eraksoy M. Validity and Reliability of the
Turkish Version of the Multiple Sclerosis-Related Symptom Checklist. Noro
Psikiyatr Ars. 2017 Dec;54(4):328-333. doi: 10.5152/npa.2016.16976. Epub 2016
Apr 26. PMID: 29321706; PMCID: PMC5758076.

Altıokka-Uzun G, Erdağ E, Baykan B, Tzartos J, Gezen-Ak D, Samancı B, Dursun
E, Zisimopoulou P, Karagiorgou K, Stergiou C, Şahin E, Ekizoğlu E, Kürtüncü M,
Tüzün E. Glial and neuronal antibodies in patients with idiopathic intracranial
hypertension. Neurol Sci. 2017 Oct;38(10):1817-1822. doi:
10.1007/s10072-017-3066-7. Epub 2017 Jul 21. PMID: 28733756.

Polat C, Tülek Z, Kürtüncü M, Eraksoy M. Validity and Reliability of the
Turkish Version of the Monitoring My Multiple Sclerosis Scale. Noro Psikiyatr
Ars. 2017 Jun;54(2):131-136. doi: 10.5152/npa.2016.12694. Epub 2017 Jan 19.
PMID: 28680310; PMCID: PMC5491662.

Kürtüncü M, Tuncer A, Uygunoğlu U, Çalişkan Z, Paksoy AK, Efendı H, Kocaman
AS, Özcan C, Terzı M, Turan ÖF, Saıp S, Karabudak R, Sıva A. Differences Between
General Neurologists and Multiple Sclerosis Specialists in the Management of
Multiple Sclerosis Patients: A National Survey. Noro Psikiyatr Ars. 2017 Jun
20;56(4):269-272. doi: 10.5152/npa.2017.19387. PMID: 31903035; PMCID:
PMC6927082.

Erdağ E, Şahin C, Küçükali Cİ, Bireller S, Küçükerden M, Kürtüncü M,
Türkoğlu R, Cakmakoglu B, Tüzün E, Arıcıoğlu F. Effects of in vivo and in vitro
administration of neuro-Behcet’s disease IgG. Neurol Sci. 2017
May;38(5):833-843. doi: 10.1007/s10072-017-2856-2. Epub 2017 Feb 21. PMID:
28224327.

Yalçınkaya N, Akcan U, Örçen A, Küçükali Cİ, Türkoğlu R, Kürtüncü M, Tüzün E. Reduced fecal GABA levels in multiple sclerosis patients. Mult Scler Relat Disord. 2016 Sep;9:60-1. doi: 10.1016/j.msard.2016.06.009. Epub 2016 Jun 28.PubMed PMID: 27645346.

Akcay Hİ, Kurtuncu M, Celik SY, Gunduz T, Eraksoy M. Neurobrucellosis presenting with mania. Acta Neurol Belg. 2017 Mar;117(1):373-375. doi:10.1007/s13760-016-0648-8. Epub 2016 May 12. PubMed PMID: 27169669.

Kürtüncü M, Tüzün E, Akman-Demir G. Behçet’s Disease and Nervous System Involvement. Curr Treat Options Neurol. 2016 May;18(5):19. doi:10.1007/s11940-016-0405-6. Review. PubMed PMID: 27007988.

Uğurel E, Şehitoğlu E, Tüzün E, Kürtüncü M, Çoban A, Vural B. Increased complexin-1 and decreased miR-185 expression levels in Behçet’s disease with and without neurological involvement. Neurol Sci. 2016 Mar;37(3):411-6. doi:10.1007/s10072-015-2419-3. Epub 2015 Nov 14. PubMed PMID: 26577184.

Akman-Demir G, Mutlu M, Kiyat-Atamer A, Shugaiv E, Kurtuncu M, Tugal-Tutkun I, Tuzun E, Eraksoy M, Bahar S. Behçet’s disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria. Clin ExpRheumatol. 2015 Nov-Dec;33(6 Suppl 94):S80-4. Epub 2015 Oct 19. PubMed PMID:26486298.

Atmaca MM, Altiokka Uzun G, Shugaiv E, Kürtüncü M, Eraksoy M. Association of Demyelinating and Inflammatory Bowel Diseases: A Case Series and Overview of the Literature. Noro Psikiyatr Ars. 2015 Sep;52(3):315-318. doi:10.5152/npa.2015.8725. Epub 2015 Jul 7. PubMed PMID: 28360731; PubMed CentralPMCID: PMC5353069.

Tüzün E, Küçükhüseyin Ö, Kürtüncü M, Türkoğlu R, Yaylım İ. Reduced serum vitamin D levels in neuromyelitis optica. Neurol Sci. 2015 Sep;36(9):1701-2. doi:10.1007/s10072-015-2229-7. Epub 2015 Apr 25. PubMed PMID: 25911291.

Küçükali CI, Kürtüncü M, Akçay Hİ, Tüzün E, Öge AE. Peripheral nerve hyperexcitability syndromes. Rev Neurosci. 2015;26(2):239-51. doi:10.1515/revneuro-2014-0066. Review. PubMed PMID: 25719304.

Altıokka-Uzun G, Tüzün E, Ekizoğlu E, Ulusoy C, Yentür S, Kürtüncü M, Saruhan-Direskeneli G, Baykan B. Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension. Cephalalgia. 2015 Nov;35(13):1153-61.doi: 10.1177/0333102415570762. Epub 2015 Feb 19. PubMed PMID: 25697366.

Tüzün E, Tzartos J, Ekizoğlu E, Stergiou C, Zisimopoulou P, Coban A, Shugaiv E, Türkoğlu R, Kürtüncü M, Baykan B, Tzartos S. Aquaporin-1 antibody in neuromyelitis optica patients. Eur Neurol. 2014;72(5-6):271-2. doi:10.1159/000364904. Epub 2014 Sep 27. PubMed PMID: 25277962.

Küçükali Cİ, Haytural H, Benbir G, Coban A, Ulusoy C, Giriş M, Kürtüncü M, Shugaiv E, Karadeniz D, Tüzün E. Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients. J Neurol Sci. 2014 Nov15;346(1-2):353-5. doi: 10.1016/j.jns.2014.08.041. Epub 2014 Aug 30. PubMed PMID:25218417.

Erdağ E, Çelebisoy N, Yüceyar AN, Kürtüncü M, Vural B, Tüzün E. Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients. Acta Neurol Belg. 2015 Jun;115(2):137-40.doi: 10.1007/s13760-014-0334-7. Epub 2014 Jul 29. PubMed PMID: 25070837.

Petek-Balcı B, Çoban A, Shugaiv E, Türkoğlu R, Ulusoy C, İçöz S, Pehlivan M, Tüzün E, Akman-Demir G, Kürtüncü M, Eraksoy M. Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis. Int J Neurosci. 2015 May;125(5):352-6. doi: 10.3109/00207454.2014.939747. Epub2014 Jul 17. PubMed PMID: 25026220.

Shugaiv E, Tüzün E, Kürtüncü M, Kıyat-Atamer A, Çoban A, Akman-Demir G,Tugal-Tutkun I, Eraksoy M. Uveitis as a prognostic factor in multiple sclerosis. Mult Scler. 2015 Jan;21(1):105-7. doi: 10.1177/1352458514539782. Epub 2014 Jun16. PubMed PMID: 24948689.

Kurtuncu M, Akhan LU, Celik S, Alkan I. Cancer awareness among universitystudents in Turkey. Asian Pac J Cancer Prev. 2014;15(10):4289-94. PubMed PMID:24935386.

Küçükali Cİ, Kürtüncü M, Çoban A, Çebi M, Tüzün E. Epigenetics of multiplesclerosis: an updated review. Neuromolecular Med. 2015 Jun;17(2):83-96. doi:10.1007/s12017-014-8298-6. Epub 2014 Mar 21. Review. PubMed PMID: 24652042.

Woodhall M, Çoban A, Waters P, Ekizoğlu E, Kürtüncü M, Shugaiv E, Türkoğlu R, Akman-Demir G, Eraksoy M, Vincent A, Tüzün E. Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitisoptica. J Neurol Sci. 2013 Dec 15;335(1-2):221-3. doi: 10.1016/j.jns.2013.08.034.Epub 2013 Sep 3. PubMed PMID: 24045088.

Vural B, Sehitoğlu E, Cavuş F, Yalçınkaya N, Haytural H, Küçükerden M, UlusoyC, Uğurel E, Turan S, Bulut L, Türkoğlu R, Shugaiv E, Kürtüncü M, Atakan S, Güre AO, Gül A, Eraksoy M, Akman-Demir G, Tüzün E. Mitochondrial carrier homolog 1(Mtch1) antibodies in neuro-Behçet’s disease. J Neuroimmunol. 2013 Oct15;263(1-2):139-44. doi: 10.1016/j.jneuroim.2013.08.007. Epub 2013 Aug 24. PubMedPMID: 24035008.

Shugaiv E, Kıyat-Atamer A, Tüzün E, Kürtüncü M, Baral-Kulaksızoğlu I, AkmanDemir G. Kleptomania in patients with neuro-Behçet’s disease. Med Princ Pract.2013;22:550-4. doi: 10.1159/000351798. Epub 2013 Jul 30. PubMed PMID: 23920112.

Durmus H, Kurtuncu M, Tuzun E, Pehlivan M, Akman-Demir G, Yapıcı Z, Eraksoy M. Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures. Acta Neurol Belg. 2013 Dec;113(4):421-6. doi:10.1007/s13760-013-0210-x. Epub 2013 May 22. PubMed PMID: 23696071.

Saruhan-Direskeneli G, Yentür SP, Mutlu M, Shugaiv E, Yesilot N, Kürtüncü M, Akman-Demir G. Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behçet’s disease. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):25-7.Epub 2013 Apr 3. PubMed PMID: 23558092.

Shugaiv E, Leite MI, Şehitoğlu E, Woodhall M, Çavuş F, Waters P, İçöz S,Birişik Ö, Uğurel E, Ulusoy C, Kürtüncü M, Vural B, Vincent A, Akman-Demir G,Tüzün E. Progressive encephalomyelitis with rigidity and myoclonus: a syndrome with diverse clinical features and antibody responses. Eur Neurol.2013;69(5):257-62. doi: 10.1159/000342237. Epub 2013 Feb 20. PubMed PMID:23429048.

Kıyat-Atamer A, Ekizoğlu E, Tüzün E, Kürtüncü M, Shugaiv E, Akman-Demir G,Eraksoy M. Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients. Eur J Neurol. 2013 May;20(5):781-7. doi:10.1111/ene.12058. Epub 2012 Dec 25. PubMed PMID: 23279782.

Kürtüncü M, Kaya D, Zuliani L, Erdağ E, Içöz S, Uğurel E, Cavuş F, Ayşit N,Birişik O, Vincent A, Eraksoy M, Vural B, Akman-Demir G, Tüzün E. CACNA1 antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL). Cephalalgia. 2013 Jan;33(2):123-9. doi:10.1177/0333102412463494. Epub 2012 Oct 30. PubMed PMID: 23111027.

Gündüz T, Emir Ö, Kürtüncü M, Mutlu M, Tumaç A, Akca S, Coban O, Bahar S,Öktem-Tanör Ö, Tüzün E, Eraksoy M, Gürvit H, Akman-Demir G. Cognitive impairment in neuro-Behcet’s disease and multiple sclerosis: a comparative study. Int J Neurosci. 2012 Nov;122(11):650-6. doi: 10.3109/00207454.2012.704454. Epub 2012Jul 12. PubMed PMID: 22720779.

Kürtüncü M, Tüzün E, Türkoğlu R, Petek-Balcı B, Içöz S, Pehlivan M, Birişik Ö, Ulusoy C, Shugaiv E, Akman-Demir G, Eraksoy M. Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: significant modulation of IL-17 and IL-23. Cytokine. 2012 Aug;59(2):400-2. doi:10.1016/j.cyto.2012.05.004. Epub 2012 May 30. PubMed PMID: 22652415.

Ulusoy C, Tüzün E, Kürtüncü M, Türkoğlu R, Akman-Demir G, Eraksoy M. Comparison of the cytokine profiles of patients with neuronal-antibody-associated central nervous system disorders. Int J Neurosci. 2012 Jun;122(6):284-9. doi:10.3109/00207454.2011.648762. Epub 2012 Jan 20. PubMed PMID: 22176581.

Uluduz D, Kürtüncü M, Yapıcı Z, Seyahi E, Kasapçopur Ö, Özdoğan H, Saip S,Akman-Demir G, Siva A. Clinical characteristics of pediatric-onset neuro-Behçet disease. Neurology. 2011 Nov 22;77(21):1900-5. doi: 10.1212/WNL.0b013e318238edeb.Epub 2011 Nov 9. PubMed PMID: 22076549.

Shugaiv E, Tüzün E, Mutlu M, Kiyat-Atamer A, Kurtuncu M, Akman-Demir G. Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet’s disease with parenchymal involvement: presentation of four cases. Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S64-7. Epub 2011 Sep 27. PubMedPMID: 21968239.

Vural B, Uğurel E, Tüzün E, Kürtüncü M, Zuliani L, Cavuş F, Içöz S, Erdağ E, Gül A, Güre AO, Vincent A, Ozbek U, Eraksoy M, Akman-Demir G. Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet’s disease. J Neuroimmunol. 2011 Oct 28;239(1-2):91-7. doi: 10.1016/j.jneuroim.2011.08.008.Epub 2011 Aug 27. PubMed PMID: 21875754.

Pehlivan M, Kürtüncü M, Yargıç I, Tüzün E. Increased alcohol consumption rates of multiple sclerosis patients and their parents. Am J Addict. 2011Sep-Oct;20(5):488-9. doi: 10.1111/j.1521-0391.2011.00165.x. Epub 2011 Jul 18.PubMed PMID: 21838854.

Bayrakli F, Kurtuncu M, Karaarslan E, Ozgen S. Perineural cyst presenting like cubital tunnel syndrome. Eur Spine J. 2012 Jun;21 Suppl 4:S387-9. doi:10.1007/s00586-011-1839-x. Epub 2011 May 15. PubMed PMID: 21574015; PubMedCentral PMCID: PMC3369044.

Pehlivan M, Kürtüncü M, Tüzün E, Shugaiv E, Mutlu M, Eraksoy M, Akman-Demir G. The comparison of socio-economic conditions and personal hygiene habits of neuro-Behçet’s disease and multiple sclerosis patients. Int J Hyg Environ Health.2011 Jul;214(4):335-7. doi: 10.1016/j.ijheh.2011.04.001. Epub 2011 Apr 22. PubMedPMID: 21514882.

Tüzün E, Erdağ E, Durmus H, Brenner T, Türkoglu R, Kürtüncü M, Lang B,Akman-Demir G, Eraksoy M, Vincent A. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis. Neurol India.2011 Jan-Feb;59(1):47-50. doi: 10.4103/0028-3886.76857. PubMed PMID: 21339658.

Tüzün E, Kürtüncü M, Türkoğlu R, Içöz S, Pehlivan M, Birişik O, Eraksoy M, Akman-Demir G. Enhanced complement consumption in neuromyelitis optica and Behçet’s disease patients. J Neuroimmunol. 2011 Apr;233(1-2):211-5. doi:10.1016/j.jneuroim.2010.11.010. Epub 2011 Jan 6. PubMed PMID: 21215465.

Akman-Demir G, Tüzün E, Waters P, Içöz S, Kürtüncü M, Jarius S, Yapıcı Z,Mutlu M, Yeşilot N, Vincent A, Eraksoy M. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol. 2011Mar;258(3):464-70. doi: 10.1007/s00415-010-5780-4. Epub 2010 Oct 17. PubMed PMID:20953960.

Türkoğlu R, Tüzün E, Içöz S, Birişik O, Erdağ E, Kürtüncü M, Akman-Demir G. Antineuronal antibodies in migraine patients with white matter lesions. Int J Neurosci. 2011 Jan;121(1):33-6. doi: 10.3109/00207454.2010.524331. Epub 2010 Oct 13. PubMed PMID: 20942595.

Bayrakli F, Erkek E, Kurtuncu M, Ozgen S. Intraventricular hemorrhage as an unusual presenting form of Sneddon syndrome. World Neurosurg. 2010 Apr;73(4):411-3. doi: 10.1016/j.wneu.2010.01.010. PubMed PMID: 20849802.

Tüzün E, Kürtüncü M, Lang B, Içöz S, Akman-Demir G, Eraksoy M, Vincent A.Bickerstaff’s encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies. Eur J Neurol.2010 Oct;17(10):1304-7. doi: 10.1111/j.1468-1331.2010.02993.x. PubMed PMID:20236177.

Içöz S, Tüzün E, Kürtüncü M, Durmuş H, Mutlu M, Eraksoy M, Akman-Demir G. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients. Int J Neurosci. 2010 Jan;120(1):71-5. doi: 10.3109/00207450903428970.PubMed PMID: 20128675.

Karaarslan E, Ulus S, Kürtüncü M. Susceptibility-weighted imaging in migraine with aura. AJNR Am J Neuroradiol. 2011 Jan;32(1):E5-7. doi: 10.3174/ajnr.A 1973.Epub 2010 Jan 14. PubMed PMID: 20075095.

Kaya D, Tüzün E, Dinçer A, Pamir MN, Kürtüncü M. A rare case of multiplesclerosis and cerebral hemorrhage associated with osteopetrosis. Diagn IntervRadiol. 2010 Mar;16(1):16-9. doi: 10.4261/1305-3825.DIR.1708-08.1. Epub 2009 Oct 5. PubMed PMID: 19813169.

Kürtüncü M, Tüzün E, Durmuş H, Mutlu M, Akman-Demir G, Eraksoy M. Primary cerebral lymphoma with a 5-year remission to single-agent corticosteroids. Leuk Lymphoma. 2009 Sep;50(9):1552-3. doi: 10.1080/10428190903128678. PubMed PMID:19637089.

Tüzün E, Bektaş HM, Içöz S, Kürtüncü M, Saip P, Akman-Demir G. Anti-Yo-associated cerebellar syndrome presenting with a brain mass. Eur J Obstet Gynecol Reprod Biol. 2009 Jun;144(2):183-4. doi: 10.1016/j.ejogrb.2009.02.046.Epub 2009 Mar 27. PubMed PMID: 19328621.

Yesilot N, Bahar S, Yilmazer S, Mutlu M, Kurtuncu M, Tuncay R, Coban O, Akman-Demir G. Cerebral venous thrombosis in Behçet’s disease compared to those associated with other etiologies. J Neurol. 2009 Jul;256(7):1134-42. doi:10.1007/s00415-009-5088-4. Epub 2009 Mar 12. PubMed PMID: 19280104.

Akman-Demir G, Ayranci O, Kurtuncu M, Vanli EN, Mutlu M, Tugal-Tutkun I. Cyclosporine for Behçet’s uveitis: is it associated with an increased risk of neurological involvement? Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S84-90.PubMed PMID: 19026121.

Akman-Demir G, Tüzün E, Içöz S, Yeşilot N, Yentür SP, Kürtüncü M, Mutlu M, Saruhan-Direskeneli G. Interleukin-6 in neuro-Behçet’s disease: association with disease subsets and long-term outcome. Cytokine. 2008 Dec;44(3):373-6. doi:10.1016/j.cyto.2008.10.007. Epub 2008 Nov 17. PubMed PMID: 19010690.

Kürtüncü M, Tüzün E. Multiple sclerosis: could it be an epigenetic disease?Med Hypotheses. 2008 Dec;71(6):945-7. doi: 10.1016/j.mehy.2008.06.034. Epub 2008 Aug 16. PubMed PMID: 18710791.

Kürtüncü M, Tüzün E, Kaya D, Içöz S, Bariş Baslo M, Ertaş M, Akman-Demir G,Eraksoy M. Anti-neuronal antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis. J Headache Pain. 2008Oct;9(5):333-5. doi: 10.1007/s10194-008-0064-4. Epub 2008 Aug 12. PubMed PMID:18696177; PubMed Central PMCID: PMC3452195.

Kurtuncu M, Battista N, Uz T, D’Agostino A, Dimitrijevic N, Pasquariello N, Manev R, Maccarrone M, Manev H. Effects of cocaine in 5-lipoxygenase-deficient mice. J Neural Transm (Vienna). 2008;115(3):389-95. doi:10.1007/s00702-007-0848-8. Epub 2008 Mar 10. PubMed PMID: 18327533.

Gürses C, Kürtüncü M, Jirsch J, Yeşilot N, Hanağasi H, Bebek N, Baykan B,Emre M, Gökyiğit A, Andermann F. Neurosyphilis presenting with status epilepticus. Epileptic Disord. 2007 Mar;9(1):51-6. Epub 2007 Feb 15. PubMed PMID:17307712.

Larson J, Jessen RE, Uz T, Arslan AD, Kurtuncu M, Imbesi M, Manev H. Impaired hippocampal long-term potentiation in melatonin MT2 receptor-deficient mice.Neurosci Lett. 2006 Jan 23;393(1):23-6. Epub 2005 Oct 3. PubMed PMID: 16203090.

Uz T, Ahmed R, Akhisaroglu M, Kurtuncu M, Imbesi M, Dirim Arslan A, Manev H. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience. 2005;134(4):1309-16. PubMed PMID:15994025.

Kurtuncu M, Luka LJ, Dimitrijevic N, Uz T, Manev H. Reliability assessment of an automated forced swim test device using two mouse strains. J Neurosci Methods.2005 Nov 30;149(1):26-30. Epub 2005 Jun 20. PubMed PMID: 15967510.

Uz T, Arslan AD, Kurtuncu M, Imbesi M, Akhisaroglu M, Dwivedi Y, Pandey GN,Manev H. The regional and cellular expression profile of the melatonin receptorMT1 in the central dopaminergic system. Brain Res Mol Brain Res. 2005 May20;136(1-2):45-53. PubMed PMID: 15893586.

Akhisaroglu M, Kurtuncu M, Manev H, Uz T. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice. Pharmacol Biochem Behav. 2005 Mar;80(3):371-7. Epub 2005 Jan 28. PubMedPMID: 15740778.

Akhisaroglu M, Ahmed R, Kurtuncu M, Manev H, Uz T. Diurnal rhythms in cocaine sensitization and in Period1 levels are common across rodent species. Pharmacol Biochem Behav. 2004 Sep;79(1):37-42. PubMed PMID: 15388282.

Uz T, Dimitrijevic N, Akhisaroglu M, Imbesi M, Kurtuncu M, Manev H. The pineal gland and anxiogenic-like action of fluoxetine in mice. Neuroreport. 2004 Mar 22;15(4):691-4. PubMed PMID: 15094477.

Kurtuncu M, Arslan AD, Akhisaroglu M, Manev H, Uz T. Involvement of the pineal gland in diurnal cocaine reward in mice. Eur J Pharmacol. 2004 Apr12;489(3):203-5. PubMed PMID: 15087244.

Eraksoy M, Hensiek A, Kurtuncu M, Akman-Demir G, Kilinc M, Gedizlioglu M, Petek-Balci B, Anlar O, Kutlu C, Saruhan-Direskeneli G, Idrisoglu HA, Setakis E, Compston A, Sawcer S; Turkish Multiple Sclerosis Genetics Study Group. A genome screen for linkage disequilibrium in Turkish multiple sclerosis. J Neuroimmunol. 2003 Oct;143(1-2):129-32. PubMed PMID: 14575930.

Eraksoy M, Kurtuncu M, Akman-Demir G, Kilinc M, Gedizlioglu M, Mirza M, Anlar O, Kutlu C, Demirkiran M, Idrisoglu HA, Compston A, Sawcer S; Turkish Multiple Sclerosis Genetics Study Group. A whole genome screen for linkage in Turkish multiple sclerosis. J Neuroimmunol. 2003 Oct;143(1-2):17-24. PubMed PMID:14575909.